Lexaria Bioscience Corp. (LXRP) financial statements (2021 and earlier)

Company profile

Business Address 100 - 740 MCCURDY ROAD
KELOWNA, BC V1X 2P7
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5691,3131,3491,7372,53393260
Cash and cash equivalents5251,2941,2851,7272,53393260
Short-term investments44196410   
Receivables4273142732664513131
Inventory, net of allowances, customer advances and progress billings1261171278767135168
Inventory1261171278767135168
Prepaid expense13618269194   
Disposal group, including discontinued operation49      
Other undisclosed current assets    150151215
Total current assets:1,3081,9261,8192,2842,795510675
Noncurrent Assets
Operating lease, right-of-use asset118127 
Property, plant and equipment452483591122 
Intangible assets, net (including goodwill)296292265147   
Intangible assets, net (excluding goodwill)296292265147   
Other undisclosed noncurrent assets    635437
Total noncurrent assets:867902856148655637
TOTAL ASSETS:2,1742,8282,6752,4322,860567712
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:838713636339033
Other undisclosed accounts payable and accrued liabilities838713636339033
Due to related parties87594884333122
Deferred revenue and credits1713 
Other undisclosed current liabilities7280     
Total current liabilities:242226185449243455
Noncurrent Liabilities
Long-term debt and lease obligation8089   45 
Long-term debt, excluding current maturities     45 
Operating lease, liability8089 
Other undisclosed noncurrent liabilities(49)(59)     
Total noncurrent liabilities:111120   45 
Total liabilities:353346185449247955
Stockholders' equity
Stockholders' equity attributable to parent1,8782,5252,3832,3883,006266772
Common stock3907976685140
Additional paid in capital30,37330,23726,17222,09616,10811,51510,818
Accumulated other comprehensive loss   (14)   
Accumulated deficit(28,498)(27,802)(23,868)(19,769)(13,170)(11,301)(10,086)
Stockholders' equity attributable to noncontrolling interest(57)(43)108 (238)(178)(116)
Total stockholders' equity:1,8212,4822,4912,3882,76888657
TOTAL LIABILITIES AND EQUITY:2,1742,8282,6752,4322,860567712

Income statement (P&L) ($ in thousands)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Revenues618385223433644115
Revenue, net644115
Cost of revenue
(Cost of Goods and Services Sold)
(156)(99)(23)(25)(30)(46)(874)
Other undisclosed gross profit      844
Gross profit:46228520040834(5)(15)
Operating expenses(4,335)(4,370)(4,358)(7,017)(1,963)(1,272)(1,968)
Operating loss:(3,873)(4,085)(4,158)(6,609)(1,929)(1,277)(1,983)
Nonoperating income (expense)
(Foreign Currency Transaction loss, before Tax)
   (1)   
Interest and debt expense    (6)(2)(32)
Other undisclosed income from continuing operations before equity method investments, income taxes9898 314   
Loss from continuing operations before income taxes:(3,775)(3,987)(4,158)(6,296)(1,935)(1,279)(2,015)
Income tax expense (2)     
Other undisclosed loss from continuing operations(2)      
Loss from continuing operations:(3,778)(3,989)(4,158)(6,296)(1,935)(1,279)(2,015)
Income from discontinued operations3     49
Net loss:(3,775)(3,989)(4,158)(6,296)(1,935)(1,279)(1,966)
Net income attributable to noncontrolling interest13315159106062164
Other undisclosed net loss attributable to parent(152)(246)(59)(324)  (181)
Net loss attributable to parent:(3,794)(4,085)(4,158)(6,609)(1,875)(1,217)(1,983)
Other undisclosed net income available to common stockholders, basic71151591062213
Net loss available to common stockholders, diluted:(3,723)(3,934)(4,099)(6,599)(1,869)(1,215)(1,771)

Comprehensive Income ($ in thousands)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Net loss:(3,775)(3,989)(4,158)(6,296)(1,935)(1,279)(1,966)
Other comprehensive income (loss)  14(14)   
Comprehensive loss:(3,775)(3,989)(4,144)(6,310)(1,935)(1,279)(1,966)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(108) (59)106062164
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (324)  32
Comprehensive loss, net of tax, attributable to parent:(3,883)(3,989)(4,203)(6,623)(1,875)(1,217)(1,771)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: